Article info

Download PDFPDF
The Impact of Percent Reduction in CA-125 Levels on Prediction of the Extent of Interval Cytoreduction and Outcome in Patients With Advanced-Stage Cancer of Müllerian Origin Treated With Neoadjuvant Chemotherapy

Authors

  1. Address correspondence and reprint requests to Haider Mahdi, Ob/Gyn and Women’s Health Institute, 9500 Euclid Ave, Cleveland, OH 44195. E-mail: mahdih6281@gmail.com.

Citation

Mahdi H, Maurer KA, Nutter B, et al
The Impact of Percent Reduction in CA-125 Levels on Prediction of the Extent of Interval Cytoreduction and Outcome in Patients With Advanced-Stage Cancer of Müllerian Origin Treated With Neoadjuvant Chemotherapy

Publication history

  • Received December 8, 2014
  • First published June 1, 2015.
Online issue publication 
June 01, 2015

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.